Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea

被引:29
作者
Cheong, HJ [1 ]
Yoo, CW [1 ]
Sohn, JW [1 ]
Kim, WJ [1 ]
Kim, MJ [1 ]
Park, SC [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul 136701, South Korea
关键词
D O I
10.1086/320873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Quinolone-resistant Escherichia coli (QREC) strains are being isolated with increasing frequency. From 1993 to 1998, 40 cases of QREC bacteremia were observed in a teaching hospital; 25 episodes (63.5%) were community-acquired. The incidence of QREC bacteremia increased steadily, from 6.7% to 24.6% during 5 years, and correlated with the significantly increased use of fluoroquinolones (P = .003, r = 0.98). When the 40 QREC bacteremic patients were compared with 80 patients with bacteremia due to quinolone-susceptible E. coli, prior fluoroquinolone use was the only independent risk factor for QREC bacteremia (P = .001). A high APACHE II score was the only independent risk factor for death. The rate of multidrug resistance of QREC was much higher (60%) than that of quinolone-susceptible isolates (13.8%). Pulsed-field gel electrophoresis patterns of these isolates were diverse. Therefore, the isolates revealed little evidence of clonal spread and may have emerged in direct response to the selective pressure exerted by prior fluoroquinolone use.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 25 条
[1]   CLINICAL ISOLATE OF CITROBACTER-FREUNDII HIGHLY RESISTANT TO NEW QUINOLONES [J].
AOYAMA, H ;
FUJIMAKI, K ;
SATO, K ;
FUJII, T ;
INOUE, M ;
HIRAI, K ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) :922-924
[2]  
AQUIAR JM, 1992, J ANTIMICROB CHEMOTH, V29, P349
[3]   INFECTION PROPHYLAXIS IN NEUTROPENIC PATIENTS WITH ACUTE-LEUKEMIA - A RANDOMIZED, COMPARATIVE-STUDY WITH OFLOXACIN, CIPROFLOXACIN AND COTRIMOXAZOLE COLISTIN [J].
ARNING, M ;
WOLF, HH ;
AUL, C ;
HEYLL, A ;
SCHARF, RE ;
SCHNEIDER, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 :137-142
[4]  
CATHERINE D, 1994, ANTIMICROB AGENTS CH, V38, P340
[5]   COMPARISON OF CIPROFLOXACIN, OFLOXACIN AND PEFLOXACIN FOR THE PREVENTION OF THE BACTERIAL-INFECTION IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES [J].
DANTONIO, D ;
PICCOLOMINI, R ;
IACONE, A ;
FIORITONI, G ;
PARRUTI, G ;
BETTI, S ;
QUAGLIETTA, AM ;
ACCORSI, P ;
DELLISOLA, M ;
FAVALLI, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (04) :837-844
[6]   INFECTION PROPHYLAXIS IN ACUTE-LEUKEMIA - A COMPARISON OF CIPROFLOXACIN WITH TRIMETHOPRIM-SULFAMETHOXAZOLE AND COLISTIN [J].
DEKKER, AW ;
ROZENBERGARSKA, M ;
VERHOEF, J .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :7-12
[7]   Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones [J].
Ena, J ;
López-Perezagua, MD ;
Martínez-Peinado, C ;
Cia-Barrio, AD ;
Ruíz-López, I .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) :103-107
[8]  
FISHER LM, 1989, AM J MED, V30, pS2
[9]   QUINOLONE RESISTANCE IN CLINICAL ISOLATES OF SERRATIA-MARCESCENS [J].
FUJIMAKI, K ;
FUJII, T ;
AOYAMA, H ;
SATO, K ;
INOUE, Y ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :785-787
[10]  
GAMBAU E, 1993, DRUGS S3, V45, P15